Clinical Trial Update: Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II pilot study investigating mixed chimerism as a treatment approach for sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Talaris Therapeutics Inc. | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: COMPLETED